This week, our team, along with our partners and colleagues from WeeCure and Cannablast, will be attending the MJBiz Conference in Las Vegas – the world’s largest cannabis convention. We’re excited to connect with industry experts and discuss key topics in edibles, cannabinoids, and vaping. If you’re keen on discussing these important issues, drop us a comment. See you there!
Welcome to Probably the most interesting Cannabinoid News in Europe!
Read the latest news about cannabinoids, their effects and WeeDutch
In the evolving landscape of the European health and wellness industry, the rise of cannabinoid businesses is a noteworthy trend. Companies like WeeDutch, a pioneering cannabinoid enterprise in the Netherlands, exemplify the swift growth and potential in this sector. This article explores the various pros and cons of starting a cannabinoid business in Europe, providing insights for entrepreneurs considering this dynamic market.
POT by NOIDS: The Game-Changing Liberation Machine for Crafting Cannabis Tinctures and Edibles at Home
Imagine having the freedom to create your own cannabis-based tinctures, oils and tasty edibles right in your own home. With POT by NOIDS, you’re not just a consumer; you’re the master of your cannabis creations. Say goodbye to complicated dispensary trips and hello to a world of possibilities. Whether you’re seeking relief from a medical condition or simply want to explore the flavorful world of cannabis-infused edibles, this innovative machine has you covered. But what makes POT by NOIDS truly special is its ease of use, giving you full autonomy without the need for any prior expertise.
Individual businesses, armed with specific knowledge and strategic moves, are the forerunners in overcoming barriers and driving the growth of Germany’s cannabinoid sector. But what is the current landscape of Germany’s cannabinoid market? How does the legal framework shape its trajectory?
The International Cannabis Business Conference in Slovenia is Europe’s newest and most exciting science and technology trade show and conference.
As European nations progressively shift toward more lenient stances on the medicinal and recreational use of cannabis, a slew of businesses are rising to meet newfound demand. However, these firms, although operating within the bounds of local law, face numerous challenges. One of the most significant barriers is the integration of eCommerce, a vital component for companies in the 21st century. From banking and finance to logistics and insurance, the hesitation from other industries to engage with the cannabis sector is palpable.
Entering this dynamic space requires strategic planning, comprehensive understanding, and a commitment to compliance. Here are 10 indispensable tips to guide entrepreneurs aiming to thrive in the EU’s cannabinoids market.
In the realm of hemp, cannabidiol (CBD), the prominent cannabinoid, has taken the spotlight for its extensively studied health potential. Yet, emerging on the scene are minor cannabinoids like cannabigerol (CBG) and cannabinol (CBN), touting their power as “new” cannabinoids with impactful properties.
H4CBD, or Hexahydrocannabidiol, is a synthesized cannabinoid created by adding four hydrogen atoms to the CBD molecule. It is claimed to be 100 times more effective than CBD, but the exact properties of H4CBD are unknown. People who use it generally report feeling similar effects as CBD but with greater psychoactivity. H4CBD is not the same as CBD and must be considered a synthetic cannabinoid.
You are here: